Monthly Communication Report

Organization:	Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration:	782797-371-106
Communication date:	2023-11-07
Posted date:	2023-12-08

Designated Public Office Holders who participated in the communication:	Gurjiven Sandhu, Director of Policy Développement économique Canada pour le Pacifique (PacifiCan) Footnote1 Jessica LaForge, Policy Advisor Développement économique Canada pour le Pacifique (PacifiCan) Footnote1
Subject Matter of the communication:	Santé,  Développement régional,  Sciences et technologies
Responsible Officer who filed this communication report:	David Renwick
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
Footnote1  Indicates new information that was added through a monthly communications return.